139 related articles for article (PubMed ID: 37964338)
21. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
22. High body mass index is a significant risk factor for the progression and prognosis of imported COVID-19: a multicenter, retrospective cohort study.
Cai H; Yang L; Lu Y; Zhang S; Ye C; Zhang X; Yu G; Gu J; Lian J; Hao S; Hu J; Zhang Y; Jin C; Sheng J; Yang Y; Jia H
BMC Infect Dis; 2021 Feb; 21(1):147. PubMed ID: 33546633
[TBL] [Abstract][Full Text] [Related]
23. Post-Discharge Symptoms among Hospitalized COVID-19 Patients in Nigeria: A Single-Center Study.
Ogoina D; James HI; Ogoinja SZ
Am J Trop Med Hyg; 2021 Jul; 105(3):731-736. PubMed ID: 34270448
[TBL] [Abstract][Full Text] [Related]
24. Clinical characteristics of 116 hospitalized patients with COVID-19 in Wuhan, China: a single-centered, retrospective, observational study.
Xiong S; Liu L; Lin F; Shi J; Han L; Liu H; He L; Jiang Q; Wang Z; Fu W; Li Z; Lu Q; Chen Z; Ding S
BMC Infect Dis; 2020 Oct; 20(1):787. PubMed ID: 33092539
[TBL] [Abstract][Full Text] [Related]
25. [Long COVID in Children: A Pediatric Center Experience].
Demirbuğa A; Hançerli Törün S; Kaba Ö; Dede E; Mete Atasever N; Eryılmaz CC; Okay NS; Somer A
Mikrobiyol Bul; 2023 Jan; 57(1):60-70. PubMed ID: 36636846
[TBL] [Abstract][Full Text] [Related]
26. Persistent COVID-19 Symptoms at 6 Months After Onset and the Role of Vaccination Before or After SARS-CoV-2 Infection.
Richard SA; Pollett SD; Fries AC; Berjohn CM; Maves RC; Lalani T; Smith AG; Mody RM; Ganesan A; Colombo RE; Lindholm DA; Morris MJ; Huprikar N; Colombo CJ; Madar C; Jones M; Larson DT; Bazan SE; Mende K; Saunders D; Livezey J; Lanteri CA; Scher AI; Byrne C; Rusiecki J; Ewers E; Epsi NJ; Rozman JS; English C; Simons MP; Tribble DR; Agan BK; Burgess TH;
JAMA Netw Open; 2023 Jan; 6(1):e2251360. PubMed ID: 36652247
[TBL] [Abstract][Full Text] [Related]
27. Risks and Cough-Aggravating Factors in Prolonged Cough. Epidemiological Observations from the Nagahama Cohort Study.
Matsumoto H; Izuhara Y; Niimi A; Tabara Y; Nagasaki T; Kanemitsu Y; Murase K; Oguma T; Ito I; Muro S; Sekine A; Matsuda F; Kosugi S; Nakayama T; Chin K; Mishima M;
Ann Am Thorac Soc; 2017 May; 14(5):698-705. PubMed ID: 28186843
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of Traditional Chinese Medicine, Maxingshigan-Weijing in the management of COVID-19 patients with severe acute respiratory syndrome: A structured summary of a study protocol for a randomized controlled trial.
Zeng C; Yuan Z; Pan X; Zhang J; Zhu J; Zhou F; Shan Z; Yuan Y; Ye R; Cheng J
Trials; 2020 Dec; 21(1):1029. PubMed ID: 33357239
[TBL] [Abstract][Full Text] [Related]
29. Severe Fatigue and Persistent Symptoms at 3 Months Following Severe Acute Respiratory Syndrome Coronavirus 2 Infections During the Pre-Delta, Delta, and Omicron Time Periods: A Multicenter Prospective Cohort Study.
Gottlieb M; Wang RC; Yu H; Spatz ES; Montoy JCC; Rodriguez RM; Chang AM; Elmore JG; Hannikainen PA; Hill M; Huebinger RM; Idris AH; Lin Z; Koo K; McDonald S; O'Laughlin KN; Plumb ID; Santangelo M; Saydah S; Willis M; Wisk LE; Venkatesh A; Stephens KA; Weinstein RA;
Clin Infect Dis; 2023 Jun; 76(11):1930-1941. PubMed ID: 36705268
[TBL] [Abstract][Full Text] [Related]
30. Excess Patient Visits for Cough and Pulmonary Disease at a Large US Health System in the Months Prior to the COVID-19 Pandemic: Time-Series Analysis.
Elmore JG; Wang PC; Kerr KF; Schriger DL; Morrison DE; Brookmeyer R; Pfeffer MA; Payne TH; Currier JS
J Med Internet Res; 2020 Sep; 22(9):e21562. PubMed ID: 32791492
[TBL] [Abstract][Full Text] [Related]
31. Analysis of influencing factors on long COVID in COVID-19 patients infected with omicron variant three months after discharge: a cross-sectional study.
Shang H; Chang T; Yang W; Shi L; Hu S; Tian L; Ren J; Wang T; Wang J; Guo J; Cui Y
BMC Infect Dis; 2024 Jan; 24(1):36. PubMed ID: 38166694
[TBL] [Abstract][Full Text] [Related]
32. Association of Age With Likelihood of Developing Symptoms and Critical Disease Among Close Contacts Exposed to Patients With Confirmed SARS-CoV-2 Infection in Italy.
Poletti P; Tirani M; Cereda D; Trentini F; Guzzetta G; Sabatino G; Marziano V; Castrofino A; Grosso F; Del Castillo G; Piccarreta R; Andreassi A; Melegaro A; Gramegna M; Ajelli M; Merler S;
JAMA Netw Open; 2021 Mar; 4(3):e211085. PubMed ID: 33688964
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness of Interferon Beta 1a, compared to Interferon Beta 1b and the usual therapeutic regimen to treat adults with moderate to severe COVID-19: structured summary of a study protocol for a randomized controlled trial.
Irvani SSN; Golmohammadi M; Pourhoseingholi MA; Shokouhi S; Darazam IA
Trials; 2020 Jun; 21(1):473. PubMed ID: 32493468
[TBL] [Abstract][Full Text] [Related]
34. The Japanese respiratory society guidelines for the management of cough and sputum (digest edition).
Mukae H; Kaneko T; Obase Y; Shinkai M; Katsunuma T; Takeyama K; Terada J; Niimi A; Matsuse H; Yatera K; Yamamoto Y; Azuma A; Arakawa H; Iwanaga T; Ogawa H; Kurahashi K; Gon Y; Sakamoto H; Shibata Y; Tamada T; Nishioka Y; Haranaga S; Fujieda S; Miyashita N; Mochizuki H; Yokoyama A; Yoshihara S; Tamaoki J;
Respir Investig; 2021 May; 59(3):270-290. PubMed ID: 33642231
[TBL] [Abstract][Full Text] [Related]
35. Three-month Follow-up Study of Survivors of Coronavirus Disease 2019 after Discharge.
Liang L; Yang B; Jiang N; Fu W; He X; Zhou Y; Ma WL; Wang X
J Korean Med Sci; 2020 Dec; 35(47):e418. PubMed ID: 33289374
[TBL] [Abstract][Full Text] [Related]
36. Sequelae, persistent symptomatology and outcomes after COVID-19 hospitalization: the ANCOHVID multicentre 6-month follow-up study.
Romero-Duarte Á; Rivera-Izquierdo M; Guerrero-Fernández de Alba I; Pérez-Contreras M; Fernández-Martínez NF; Ruiz-Montero R; Serrano-Ortiz Á; González-Serna RO; Salcedo-Leal I; Jiménez-Mejías E; Cárdenas-Cruz A
BMC Med; 2021 May; 19(1):129. PubMed ID: 34011359
[TBL] [Abstract][Full Text] [Related]
37. Rates of ICD-10 Code U09.9 Documentation and Clinical Characteristics of VA Patients With Post-COVID-19 Condition.
Wander PL; Baraff A; Fox A; Cho K; Maripuri M; Honerlaw JP; Ho YL; Dey AT; O'Hare AM; Bohnert ASB; Boyko EJ; Maciejewski ML; Viglianti E; Iwashyna TJ; Hynes DM; Osborne TF; Ioannou GN
JAMA Netw Open; 2023 Dec; 6(12):e2346783. PubMed ID: 38064215
[TBL] [Abstract][Full Text] [Related]
38. 3-year outcomes of discharged survivors of COVID-19 following the SARS-CoV-2 omicron (B.1.1.529) wave in 2022 in China: a longitudinal cohort study.
Zhang H; Huang C; Gu X; Wang Y; Li X; Liu M; Wang Q; Xu J; Wang Y; Dai H; Zhang D; Cao B
Lancet Respir Med; 2024 Jan; 12(1):55-66. PubMed ID: 38000376
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
